6808.TWO 3D Global Biotech Inc.

Healthcare Biotechnology Taiwan OTC Exchange
26.55 TWD
Close of Nov 6, 2026
22.38 51.33
Market cap
TWD 2.04B
P/E
147.5x
P/B
2.90x
ROE
6.8%
Dividend yield
2.02%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 6808.TWO undervalued?

Graham number

The Graham number of 3D Global Biotech Inc. cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

3D Global Biotech Inc. fundamental analysis

No fundamental analysis for 3D Global Biotech Inc. yet.

3D Global Biotech Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About 3D Global Biotech Inc.

3D Global Biotech Inc. manufactures and sells medical devices for human body reconstruction. It offers artificial bone grafting; 3D bioForming; bio-dressing; 3D bioture EX; 3D printing equipment, such as 3D BioRealizer system; orthodontic aligner system under the SmileAlign name; and iMatrix, a sectional matrix kit. The company was founded in 2014 and is based in New Taipei City, Taiwan.

Full company profile